Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial

PaperCitations, authors & open-access status

Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 91 citations, 2021 year and green oa status.

91
Citations
2021
Year
green
OA Status

Related on ScholarIQ

Andrew E. Petroll
Author
HIV/AIDS drug development and treatment
Topic
HIV/AIDS drug development and treatment
Topic
HIV/AIDS Research and Interventions
Topic
HIV-related health complications and treatments
Topic
470M+ articles · free account